期刊文献+

胸腔镜下肺癌的根治性手术编码探讨

Discussion on Coding of Radical Surgery for Lung Cancer under Thoracoscopy
原文传递
导出
摘要 胸腔镜下肺癌的根治性手术已成为治疗肺癌的新型手术方式,通过回顾5例肺癌患者的病案,针对胸腔镜下肺癌的根治性手术的不同术式和手术步骤介绍按照ICD-9-CM-3原则进行编码,旨在提高手术编码的准确性和统一性。胸腔镜下肺癌的根治性手术根据病变的切除范围,有5种常见术式及编码:胸腔镜下肺楔形切除术32.20;胸腔镜下肺段切除术32.30;胸腔镜下肺叶切除术32.41;胸镜下袖式肺叶切除术32.41+32.1+38.35;胸腔镜下全肺切除术32.50。编码工作要正确理解手术原理、目的,读懂手术记录,在此基础上结合ICD-9-CM-3的编码规则,根据不同术式给予相应的编码。要求编码人员要有较高的专业素质,了解相关临床知识,仔细阅读病案,加强与临床医师的沟通,同时规范临床医师的书写习惯,建立有效的质控体系,以提高病案编码质量。 In recent years, Radical surgery for lung cancer under thoracoscopy has become a new surgical procedure for lung cancer, By reviewing five cases of lung cancer, different surgical procedures and procedures for radical thoracoscopic lung cancer: how to code according to ICD-9-CM-3 principles, The aim is to improve the accuracy and unity of surgical coding. Radical surgery for lung cancer under thoracoscopy, Here are the following common procedures and coding: thoracoscopic wedge resection 32.20;Thoracoscopic pneumonectomy 32.30;Thoracoscopic lobectomy 32.41;Thoracic sleeve lobectomy 32.41+32.1+38.35;Thoracoscopic total pneumonectomy 32.50. To understand the principle and purpose of the operation correctly, read the records, based on the ICD-9-CM-3 coding rules, according to different procedures to give the corresponding coding. Requires the coding personnel to have the higher professional quality, knowledge of clinical knowledge, read the medical records carefully, strengthen communication with clinicians, And regulate clinicians’ writing habits, establish an effective quality control system, in order to improve the quality of medical record coding.
作者 池旎 Chi Ni(Department of Medical Records,The Union Hospital Affiliated Hospital of Fujian Medical University,Fuzhou 350001,Fujian Province,China)
出处 《中国病案》 2021年第4期39-41,共3页 Chinese Medical Record
关键词 胸腔镜下肺癌的根治性手术 术式 手术编码 Radical surgery for lung cancer under thoracoscopy Surgical procedure Coding
  • 相关文献

参考文献8

二级参考文献63

  • 1刘鹏.下肢静脉曲张的临床治疗[J].中国血管外科杂志(电子版),2013,5(1):4-5. 被引量:16
  • 2谢锦艳.病案首页填写中主要诊断对ICD-10编码的影响[J].医学信息(西安上半月),2006,19(10):1735-1736. 被引量:1
  • 3刘春玲,邓应梅,肖蓓.谈临床医师应正确认识主要诊断[J].中华医院管理杂志,2007,23(5):352-353. 被引量:15
  • 4孙燕,赵平.临床肿瘤学进展[M].北京:中国协和医科大学出版社,2006:602-603.
  • 5Reif M, Socinski MA, Rivera MP. Evidence-based medicine in the treatment ofnon-smai1 celllung cancer. Clin Chest Med, 2000, 21(1): 107-120.
  • 6Scott W, Howington J, Movsas B. Treatment of stage Ⅱ non-small cell lung cancer. Chest, 2003, 123(Suppl 1): 188-201S.
  • 7Smythe W. Treatment of stage I non-small cell lung carcinoma. Chest, 2003, 123(Suppl 1): 181S-187S.
  • 8Okada M, Toshihiko S, Tsuyoshi Y, et al. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Tnorac Surg, 2006, 81(3): 1028-1032.
  • 9Asamura H, Nakayama H, Kondo H, et al. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg0 1999, 117(6): 1102-1111.
  • 10Turna A, Solak O, Kilicgun A, et al. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy? Thorac Cardiovasc Surgy 2007, 55(2): 112-119.

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部